| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Levy Richard S serves as a Director at TARA and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 23 buys and 47 sells. Those positions are worth an estimated $206K at current prices.
Historically, Levy Richard S's trades have earned a below-average insider score of 44/100 across 6 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -19.2%.
The biggest single holding is TARA (~$163K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 20,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sell10b5-1 | 5,682 | $515.44 | $2,928,716.43 | -20.5% | +0.4% | - | |
| Nov 13, 2025 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 8,500 | $520.96 | $4,428,197.57 | -28.6% | -6.6% | - | |
| May 14, 2025 | TARA Protara Therapeutics, Inc. | Director | Buy | 20,000 | $3.19 | $63,800.00 | +64.5% | -1.9% | - | |
| Nov 7, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 5,000 | $350.00 | $1,750,000.00 | -31.2% | -4.2% | +37.9% | |
| Nov 1, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 5,000 | $300.94 | $1,504,703.41 | -31.2% | +5.9% | +31.1% | |
| Apr 1, 2024 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 11,000 | $257.48 | $2,832,334.60 | -51.6% | +9.2% | +26.7% | |
| Jan 17, 2023 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Sale+OE | 22,489 | $293.15 | $6,592,685.55 | -71.2% | -13.1% | -18.7% | |
| Mar 20, 2020 | KOD Kodiak Sciences Inc. | Director | Buy | 1,000 | $44.33 | $44,330.00 | New | - | - | |
| Aug 23, 2017 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 2,000 | $16.12 | $32,235.91 | +28.2% | - | - | |
| Aug 22, 2017 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 3,550 | $16.12 | $57,209.06 | +100.0% | - | - |